Lind L(1), Sundström J(2)(3), Ärnlöv J(4)(5), Risérus U(6), Lampa E(7). Author information:
(1)Department of Medical Sciences, Uppsala University Hospital, Uppsala
University, 751 85, Uppsala, Sweden. [Email]
(2)Department of Medical Sciences, Uppsala University Hospital, Uppsala
University, 751 85, Uppsala, Sweden.
(3)The George Institute for Global Health, University of New South Wales,
Sydney, NSW, Australia.
(4)Division of Family Medicine and Primary Care, Department of Neurobiology,
Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
(5)School of Health and Social Sciences, Dalarna University, Falun, Sweden.
(6)Department of Public Health and Caring Sciences, Uppsala University, Uppsala,
(7)Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
The impact of most, but not all, cardiovascular risk factors decline by age. We investigated how the metabolic syndrome (MetS) was related to cardiovascular disease (CVD) during 40 years follow-up in the Uppsala Longitudinal Study of Adult Men (ULSAM, 2,123 men all aged 50 at baseline with reinvestigations at age 60, 70, 77 and 82). The strength of MetS as a risk factor of incident combined end-point of three outcomes (CVD) declined with ageing, as well as for myocardial infarction, ischemic stroke and heart failure when analysed separately. For CVD, the risk ratio declined from 2.77 (95% CI 1.90-4.05) at age 50 to 1.30 (95% CI 1.05-1.60) at age 82. In conclusion, the strength of MetS as a risk factor of incident CVD declined with age. Since MetS was significantly related to incident CVD also at old age, our findings suggest that the occurrence of MetS in the elderly should not be regarded as innocent. However, since our data were derived in an observational study, any impact of MetS in the elderly needs to be verified in a randomized clinical intervention trial.
Having over 250 Research scholars worldwide and more than 400 articles online with open access.